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1. Introduction  
Preterm births cause a large public-health burden because of its high prevalence, leading 
cause of neonatal morbidity and mortality, and environmental hazards is considered to be a 
potential risk factors (Adams et al., 2000; Bloom et al., 2001; Tucker & McGuire, 2004; Colvin 
et al. 2004; Fraser et al. 2004; Murphy et al. 2004). The frequency of preterm births is about 
12–13% in the USA and 5–9% in many other developed countries; however, the rate of 
preterm birth has increased in many locations (Goldenberg et al., 2008). Thus, to elicit of risk 
factors that could predict high risk of preterm birth represents a challenge to practitioners 
and researchers. The increasing rate of preterm birth in recent decades, despite 
improvements in health care, creates an impetus to better understand and prevent this 
disorder. The identification of women at increased risk of preterm delivery is an important 
challenge. Preterm birth likely depends on a number of interacting factors, including 
genetic, epigenetic, and environmental risk factors (Windham et al., 2000; Plunkett & 
Muglia, 2008). The epidemiological data suggested that both genetic factors and 
socioenvironmental factors may influence preterm birth (Wang et al., 2000; Nukui et al., 
2004; Lewis et al., 2006; Suh et al., 2008). 
Genetic studies may identify stable over time markers, which can predict preterm birth in 
genetically susceptible subjects and the gene-environment studies may explain how the 
variations in the human genome (polymorphisms) can modify the effects of exposures to 
environmental health hazards (Kelada et al., 2003). Given individual genetic variations of 
pregnant women and different environmental exposures, the study may reveal women 
group susceptible to environmental hazards and may explain the differences in risk of 
preterm birth among individuals exposed to a particular environmental toxicant (Rothman 
et al., 2001). Furthermore, enhanced understanding of pathologic mechanisms may allow 
the development of interventions that can be used to prevent or treat preterm birth. 
To date, however, only a relatively few studies on the association of gene-environment 
interactions with preterm birth have been published (Wang et al., 2002; Genc et al., 2004; 
Macones et al., 2004).  
Experimental and epidemiologic studies provide evidence that a number of drinking water 
disinfection by-products (DBPs), including trihalomethanes (THM), may be associated with 
adverse pregnancy outcomes. Epidemiological studies suggested that pregnant women 
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exposed to water containing elevated THM concentrations may be at greater risk for adverse 
pregnancy outcomes, including fetal growth, but findings of the studies to date have been 
inconsistent (Nieuwenhuijsen et al., 2000; Graves et al., 2001; Bove et al., 2002). The 
relationship between DBPs exposure and reproductive health outcomes remains unclear, 
mainly owing to limitations in the crude exposure assessment in most studies (Tardiff et al., 
2006; Yang et al., 2007; Nieuwenhuijsen et al., 2009).  
A recent meta-analysis of epidemiologic studies data on the association of THMs 
concentration in water and birth outcome, without taking into account exposure routes, 
concluded that there was little or no evidence for associations between THM concentration 
and prematurity and fetal growth, and that the uncertainties-relating particularly to 
exposure that may have affected them (Grellier et al., 2010). In addition, some 
epidemiological studies show little evidence for an association between THM and preterm 
birth, term low birth weight and other adverse birth outcomes (Bove et al., 2002; Hinckley et 
al., 2005; Nieuwenhuijsen et al., 2009). These epidemiological studies of reproductive 
outcomes had relied on different methods of assessing exposure, which presents difficulties 
in making comparisons between investigations and in generalizing results. The 
inconsistency of the association between exposure to THM and birth outcomes also could be 
related to both – qualitative and quantitative differences in exposure between the compared 
studies (Jaakkola et al., 2001). So, a major challenge in studies that examine the association 
between DBPs in drinking water and pregnancy outcomes is the accurate representation of a 
subject’s exposure (King et al., 2004).  
Seeking to improve the exposure assessment, studies have begun to incorporate behavioural 
determinants of different routes of exposure to DBPs such as dermal absorption and 
inhalation during bathing and showering, and ingestion of drinking water (Savitz et al. 
2006; Hoffman et al., 2008; MacLehose et al., 2008). In our previous prospective Kaunas 
cohort study, which incorporated of different routes of exposure to THMs, we found dose–
response relationships for entire pregnancy and trimester-specific gestational THMs and 
chloroform internal dose for low birth weight and reduction in birth weight (Grazuleviciene 
et al., 2011).  
The epidemiological studies concluded that, while there appears to be suggestive evidence 
associating elevated total THM levels with some adverse reproductive outcomes, evidence 
for relationships with preterm birth and fetal growth is inconclusive and inconsistent 
(Richardson et al., 2003; Lewis et al., 2006; Grellier et al., 2010). 
Most of the previous investigations have evaluated crude THM exposure; these studies 
differed on control of maternal characteristics that could also to be associated with adverse 
pregnancy outcomes; these studies did not evaluated genetic susceptibility to individual 
THM in relation to adverse pregnancy outcomes. Polymorphic variation in metabolic genes 
involved in detoxification of xenobiotics may explain some of the variation in individual 
susceptibility to the adverse effects of pollutants on preterm birth. 
There is now some evidence concerning adverse effects of traffic-related air pollution on 
pregnancy outcomes and infant health. The evidence is suggestive of causality for the 
association of birth weight with air pollution, although for preterm birth and fetal growth, 
the current evidence is insufficient to infer a causal relationship and effects were not always 
consistent between studies Maisonet et al., 2001; Maroziene & Grazuleviciene, 2002; Sram et 
al., 2005; Dugandzic et al., 2006). Nitrogen dioxide (NO2) is considered as a marker for air 
pollution from traffic associated with health effects (Belander et al., 2001; Rijnders et al., 
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2001). In addition, a number of epidemiological studies have found various level 
relationships between exposures to traffic-related air pollution and birth outcomes, 
particularly for NO2 and particulate matter, suggesting that exposure to these air pollutants 
may increase a woman’s risk for preterm birth (Bobak, 2000; Maroziene & Grazuleviciene, 
2002; Leem et al., 2006; Llop et al., 2010; Gehring et al., 2011).  
The biological mechanisms by which air pollutants may interfere with the processes of 
prenatal development are still not clear. Several potential mechanisms have been 
hypothesised, including increased maternal susceptibility to inflammation, oxidative stress 
(Mohorovic, 2004; Becker et al., 2005; Risom et al., 2005), haematological factors (e.g., blood 
viscosity) (Pekkanen et al., 2000; Liao et al., 2005;) and the direct effect of specific pollutants 
on foetal development or on DNA and its transcription (Perera et al., 1999; Sram et al., 1999). 
Nitrogen dioxide is capable of oxidising tissue components (e.g., proteins, lipids) and of 
suppressing the antioxidant protective systems of organism (Sagai & Ichinose, 1991). 
Increased lipid peroxidation in the maternal and/or foetal compartment has been found in 
preterm birth (Moison et al., 1993). It was suggested that maternal exposure to NO2 can 
increase the risk of pregnancy complications through stimulation of the formation of cell 
damaging lipid peroxides and from decrease in maternal antioxidant reserves (Tabacova et 
al., 1998). Recently a few potential biological mechanisms have been described through 
which air pollution could influence pregnancy outcomes, such as the induction 
inflammation of placenta, respiratory system and cardiovascular mechanisms of oxidative 
stress, coagulation, endothelial function, and hemodynamic responses (Kannan et al., 2006). 
A crucial aspect of the study of prenatal exposure to air pollutants is the identification of 
vulnerable periods to the detrimental effects of the exposure during pregnancy and sensitive 
subjects (Hackley et al., 2007; Woodruff et al., 2009). Molecular epidemiological studies 
suggest possible biological mechanisms for the effect on preterm birth and intrauterine 
growth retardation (Shin, 2008). Population-based study data showed that 25% of the 
variation in preterm birth was explained by maternal genetic factors, fetal genetic factors 
only marginally influenced the variation in liability, while 70% of the variation in preterm 
birth was explained by the environmental effects (Svensson et al., 2009). More research is 
needed to clarify the role of traffic-related hazards on preterm birth, as well as their 
interactions with other environmental hazards and with specific genetic factors affecting 
maternal susceptibility.  
In the present study, using individual cohort study data and adjusting for many important 
risk factors for preterm birth, we evaluated the effect of trimester-specific gestational THM 
internal dose and residential NO2 exposure for preterm birth among genetically susceptible 
women. In our study individual exposure to THM was estimated as total internal dose 
based on monitoring of tap water THM levels and detailed water use behaviours.  
Controlling for influence of potential confounding variables, we seek to investigate whether 
the polymorphisms of metabolic genes GSTT1 and GSTM1 affect the association of maternal 
exposures to THMs and NO2 with preterm birth risk. 
2. Methods 
We conducted a prospective cohort study of 4,161 pregnant women in Kaunas (Lithuania). 
We used tap water THM concentrations, geocoded maternal address at birth, individual 
information on drinking water ingestion, showering and bathing, and uptake factors of 
THMs in blood, to estimate an internal dose of THM. We estimated maternal residential 
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exposure to NO2 by Airviro dispersion models during entire pregnancy, and three 
pregnancy trimesters and used logistic regression to evaluate the relationship between 
internal THM dose and NO2 exposure and preterm birth controlling for potential 
confounding variables. To investigate whether the polymorphisms of metabolic genes 
GSTT1 and GSTM1 affect the association of maternal exposure to THMs and NO2 with 
preterm birth risk, a nested case-control study on preterm birth occurrence among 682 
women with genotyping of GSTT1 and GSTM1 polymorphisms was conducted. 
2.1 Participant recruitment and outcome assessment 
We conducted a prospective cohort study of pregnant women in Kaunas city, Lithuania. On 
their first visit to a general practitioner, all pregnant women living in Kaunas city between 
2007 and 2009 were invited to join the cohort. The women were enrolled in the study only if 
they consented to participate in the cohort. The study ethics complied with the Declaration 
of Helsinki (1996). The research protocol was approved by the Lithuanian Bioethics 
Committee and an oral informed consent was obtained from all subjects. In total 5,405 
women were approached; 79% of them agreed to participate in the study. 
The first interview was completed during the first pregnancy trimester. The median 
gestational age at interview was 8 weeks. The interview queried women regarding 
demographics, residence and job characteristics, chronic diseases (cardiovascular, 
hypertension, diabetes, renal), reproductive history, including date of last menstrual period, 
previous preterm delivery. We also asked the women to report their age (less than 20 years, 
20–29 years, 30 years, and more), educational level (primary, secondary, university), marital 
status (married not married), smoking (non-smoker, smoker at least one cigarette per day), 
alcohol consumption (0 drinks per week, at least one drink per week), blood pressure 
(<140/80 mm/Hg, ≥140 or ≥ 90 mm/Hg), body mass index (<25 kg/m2, 25–30 kg/m2, >30 
kg/m2), and other potential risk factors for preterm birth. Adjustment for these variables 
was made for studies of various subgroups. The women also were examined by ultrasound 
to determine the gestational age of the foetus. 
A special water consumption and water use habits questionnaire was used to interview the 
4,260 women who agreed to participate in the study; 76.4% of them were interviewed during 
the third pregnancy trimester before delivery at the hospital and 23.6% by telephone within 
the first month after delivery. Consumption was ascertained for three types of water: cold tape 
water or dinks made from cold tap water; boiled tap water (tea, coffee, and other); and bottled 
water, used at home, at work, other. In addition, number of showers, baths, swimming pools 
weekly, and their average length was asked of all subjects. The interviews were conducted by 
trained nurses who did not know the THM exposure status and birth outcome. 
Pregnancy outcomes were abstracted from the medical records. Preterm birth was defined 
as infant’s whose gestational age was less than 37 weeks. Gestational age of the foetus was 
estimated as the difference between the delivery date and the date of the last menstruation 
as reported by the women at the beginning of their pregnancies, and of an ultrasound 
examination. The reference group was defined as all term births (born at >37 weeks of 
gestation).  
Women with multiple pregnancies (150), having inconsistent or invalid data for dating the 
pregnancy (5) or estimating THM exposure (mostly students moved out of the city during 
pregnancy, 839) or with newborn birth weight above 4,500 g (75) were excluded. We 
restricted our analyses to infants born with a birth weight below 4,500 g, leaving data for 
3,341 women in the final analysis. 
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2.2 THM exposure assessment  
The Kaunas city municipal drinking water is supplied by four water treatment plants 
system. The each treatment plant water supplied system is constituted of only one 
subsystem (i.e., one chlorination, and branchy water supplied to the users). Groundwater 
sources are used for the whole water supply system. 
However, the four water treatment plants, which disinfected ground water with sodium 
hypochlorite (chlorine dose 0.26–0.91 mg/L, residual chlorine 0–0.22 mg/L), produced 
different concentrations of THMs in finished water. One treatment plant (Petrasiunai) 
supplied finished water with higher levels of THMs (“high level THM site,” 54.9% subjects), 
and the three other plants supplied finished water with lower levels of all THMs (“low level 
THM site”). Water samples were collected four times per year over a 3-year study period 
(2007–2009) in the morning in three locations: close to the treatment plant, at 5 km, and at 10 
km or more from every treatment plant. A total of 85 water samples were collected from 12 
monitoring sites in four water supply zones for THM analysis.  
Samples were analysed at the University of the Aegean, Greece, by using gas 
chromatography with electron captures detection (Nikolaou et al., 2005). Measurements 
included specific values for the four regulated THMs (chloroform, bromoform, 
bromodichloromethane, and dibromochloromethane). We calculated the mean quarterly 
THM constituent concentrations for water zones and subsequently, depending on the 
TTHM levels within each zone, assigned “low level” and “high level” sites. We used tap 
water THM concentration, derived as the average of quarterly sample values over the time 
that the pregnancy occurred from all sampling sites located in the each distribution system, 
and geocoded maternal address at birth to assign the individual women residential 
exposure index. Estimates of exposure index to total and specific THMs from drinking water 
were tabulated first as an average level at the tap over the pregnancy period; this measure 
was then categorized at the tertiles of the distribution for birth outcomes. In addition, 
trimester-specific analyses were conducted. We combined every subject’s residential 
exposure index and water-use questionnaire data to assess individual exposure through 
ingestion of THMs. Women were asked to indicate the cup or glass size and number of cups 
or glasses of tap water consumed per day, including hot and cold beverages made from tap 
water. With this information, we calculated daily amounts of hot and cold tap water 
ingested. Integration of the information on residential THM levels (μg/L), ingested amounts 
(L/day), and modifications by heating using an estimated uptake factor of 0.00490 to derive 
an integrated index of blood concentration, expressed in micrograms per day (μg/d) (Savitz 
et al., 2006; Whitaker et al., 2003). 
The actual algorithms of internal dose from ingestion were:  
chloroform level (μg/l) × water consumption (l/day) × 0.00490196 μg/μg/l; 
brominated THM level (μg/l) × water consumption (l/day) × 0.00111848 μg/μg/l. 
We assumed a null THM level for any bottled water consumption since in local bottled 
water production chlorination and ozonation is not used. 
Finally, we addressed dermal absorption and inhalation by considering showering and 
bathing alone and combined with ingestion. We multiplied residential THM levels (μg/L) 
by frequency and average duration of bathing or showering per day (min/day) and 
calculated each mother’s trimester-specific and entire pregnancy average daily uptake of 
THM internal dose (μg/d). We derived indices of daily uptake by integrating THM 
concentrations, duration of bathing and showering reported in a questionnaire administered 
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to study participants, and estimated uptake factors of 0.001536 and 0.001321 of THMs in 
blood per minute per microgram from showering and bathing, respectively (Backer et al., 
2000; Lynberg et al., 2001). The uptake factors of THMs individual constituents were 
assessed on the relative changes in blood levels after 10 minutes exposure (after versus 
before ingestion 1 L of tap water, 10 minutes showering, and 10 minutes bathing). The actual 
algorithms of internal dose from showering and bathing were: 
min/day showering × μg/l chloroform in water × 0.001536261 μg/min/μg/l, 
min/day showering × μg/l brominated THM in water × 0.001352065 μg/min/μg/l, 
min/day bathing × μg/l chloroform in water × 0.001320755 μg/min/μg/l, 
min/day bathing × μg/l brominated THM in water × 0.00129571 μg/min/μg/l 
We then used average daily total uptakes in our analysis as continuous and categorized 
variables. We calculated tertiles of THM internal dose. This gave first (0.0025–0.0386 μg/d), 
second (0.0386–0.3496 μg/d), and third (0.3496–2.4040 μg/d) tertiles for average TTHM 
uptake. To reduce exposure misclassification errors in the subsequent analysis, we used a 
subset of women who through the entire pregnancy did not change their address. 
2.3 NO2 exposure assessment  
In this study exposure to ambient NO2 pollution estimates at each cohort number home 
address was assigned using GIS and AIRVIRO dispersion model, developed by the Swedish 
Meteorological and Hydrological (Airviro User Documentation 1997). The model integrates 
emissions inventories, meteorological data (wind direction and speed, temperature), 
background pollution measurements as input parameters and land use. Kaunas streets NO2 
emission data were used to create emission database within AIRVIRO Air Quality 
Management System. Gaussian plume dispersion simulations were run for a model domain 
encompassing the entire city area on a course grid resolution.  
Geographic data for the Kaunas city streets, its type were measured by combination GIS and 
manual measurements. Total traffic counts and its composition (calculated as cars/day 
time’s km street length) were measured based on the 2008 Municipal traffic-count data for 
Kaunas. If no counts were available for specific street, the numbers were estimated by a 
person with local information about the traffic conditions based on comparison with roads 
on which data were available. Traffic count data were available for 80% of the streets nearest 
to cohort addresses. 
To attribute the NO2 exposure to every study subject, the health data base and the 
environmental NO2 pollution data base were joined. Every subject’s full street address and 
residential NO2 pollution level measurement data, and the current residence history data 
were combined to assess the individual NO2 pollution exposure. A GIS assigning NO2 
pollution level was used for every woman by applying different GIS functions and 
possibilities. First, the study subjects data were converted to a database file structure for use 
in GIS software (ArcInfo version 9.3, ESRI). Geocoding was performed to obtain latitude and 
longitude coordinates for each patient’s home address. Initially, 63 % records were matched 
and 37 % were left unmatched. All unmatched records were reviewed and corrected, 
leading to another 37 % matched addresses (total of 3287). Then, a spatial join was perform 
that allows the GIS user to append the attributes of one data layer (patient address points) to 
the attributes of another layer (nitrogen dioxide) assessed with AIRVIRO. We established 
the individual outdoor NO2 exposure during three trimesters and entire pregnancy for 
every subject at the geocoded residential address.  
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2.4 Genotyping 
Within the prospective cohort study, a nested case-control study on preterm birth occurrence 
among 682 women with genotyping of GSTT1 and GSTM1 polymorphisms was conducted. 
This study was assumed to identify gene–environment interaction that increases the risk of 
preterm delivery. We investigated the association between the risk of preterm delivery and 
each metabolic gene of glutathione S-transferases mu 1 (GSTM1) and theta 1 (GSTT1) along 
with exposure to THM and NO2. The GSTM1-null and GSTT1-null genotypes were identified 
by the multiplex polymerase chain reaction (PCR) in peripheral blood DNA samples.  
 For genetic analysis maternal blood samples were collected in vials containing EDTA and 
stored at a temperature of −20 °C. DNA was purified from the peripheral blood using DNA 
purification kits (SORPOclean Genomic DNA Extraction Kit, Vilnius, Lithuania). DNA 
concentrations were quantified with a spectrophotometer (Eppendorrf BioPhotometer, 
61310488, Hamburg, Germany). The GSTM1- and GSTT1-null genotypes were identified by 
the multiplex polymerase chain reaction (PCR) in peripheral blood DNA samples. Multiplex 
PCR was performed as described by Arand et al. (1998) to determine the present (at least 1 
allele present: AA or Aa) or absent (complete deletion of both alleles: aa) of GSTM1 and 
GSTT1 genes. PCR condition could be found elsewhere (Grazuleviciene et al., 2009).  
2.5 Statistical analysis 
The data analysis compared the preterm birth of low, medium and high exposed women to 
THMs. We used logistic regression to estimate adjusted odds ratios (ORs) and 95-percent 
confidence intervals (CIs) for preterm birth and the various exposure indices. We 
categorized TTHM internal dose in tertiles and evaluated the possible relationship between 
increases in preterm birth risk for an increase in estimated TTHM internal dose. We ran 
multivariate logistic regression models for the TTHMs, chloroform, dibromochloromethane, 
and bromodichloromethane for the total pregnancy and trimester specific periods. We also 
used multiple linear regressions for TTHM internal dose analysis as continuous variable to 
evaluate the relationship, if any between preterm birth and every 1 μg/d increase in TTHM 
internal dose. 
In the logistic regression models for preterm birth outcome, using personal data of the 
cohort sample, we assessed a variety of potential confounders identified by univariate 
analysis. Further, we examined the association of THM exposure and preterm birth with a 
multivariable analysis controlling for effect of major covariates that changed the adjusted 
ORs for THM by 10% or more. The adjusted preterm birth outcome analyses included 
maternal smoking, education, family status, chronic diseases, previous preterm birth, stress 
and infant birth year.   
The effect of ambient NO2 exposure on preterm birth was estimated by logistic regression. 
We grouped the NO2 concentrations into three categories (tertiles) and applied the exposure 
variable as both categorical and continuous parameters. We used exposure levels in the 1st 
tertile as the reference category (low exposure) and then also conducted an analysis of 
continuous exposure parameters on the basis of an increase of 10 μg/m3 in NO2 
concentrations. We calculated crude and adjusted odds ratios (OR) and their 95 % 
confidence intervals (CIs) of preterm birth exposure categories. Statistical analyses were 
performed with SPSS software for Windows version 13. 
To investigate whether the polymorphisms of metabolic genes GSTT1 and GSTM1 affect the 
association of maternal exposure to THMs and NO2 with preterm birth risk, a nested case-
control study data on preterm birth occurrence among 682 women with genotyping of 
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GSTT1 and GSTM1 polymorphisms was analysed. Logistic regression analyses were 
performed to explore the impact of each gene, THM and NO2 exposure and their effect on 
the risk of preterm birth. The subgroups were defined by maternal genotype for GSTT1 
(present, absent) and GSTM1 (present, absent) and maternal exposure to THM status during 
pregnancy (above median/below median). We run multivariate logistic regression models 
for the TTHMs, chloroform, dibromochloromethane, and bromodichloromethane for total 
gestational and trimester-specific periods, while adjusting for potential confounders. 
Similarly we run analysis for the NO2. We used logistic regression to estimate adjusted odds 
ratios (ORs) and 95-percent confidence intervals (CIs) for preterm birth, and the various 
exposure indices. 
We estimated the exposure effect for GSTT1 (present, absent) and GSTM1 (present, absent) 
genotypes by a multivariable analysis controlling for influence of major covariates that 
changed the adjusted ORs for NO2 by 10% or more. Two-tailed statistical significance was 
evaluated by using a p value of 0.05. All statistical analyses were carried out using the SPSS 
software for Windows version 12.0.1. 
3. Results 
3.1 Daily THM uptake 
The mean tap water THM level in the low level site from three water treatment plants was 
1.3 µg/L, and in the high level site (Petrasiunai) 21.9 µg/L (Table 1). The estimated 
individual total uptake of THMs ranged between 0.0025 and 2.40 g/d. The total chloroform 
uptake ranged between 0.0013 and 2.13 g/d. Mothers supplied with water who had a 
higher chloroform concentration generally also had a higher total internal dose. Daily 
uptake of bromodichloromethane ranged between 0.0001 and 0.34 g/d and 
dibromochloromethane ranged between 0 and 0.064 g/d. Bromoform was below the limit 
of detection. 
 
Tap water sampling 
sites 
TTHMsc 
Mean (SDd) 
CHCl3 
Mean (SD) 
CHBr2Cl 
Mean (SD) 
CHBrCl2 
Mean (SD) 
All sites 
Low THM levela 
High THM levelb 
9.8 (12.4) 
1.3 (1.2) 
21.9 (10.9) 
7.8 (10.2) 
0.9 (1.0) 
17.7 (9.0) 
0.3 (0.5) 
0.1 (0.2) 
0.5 (0.6) 
1.7 (2.2) 
0.3 (0.5) 
3.6 (2.1) 
aViciunai, Eiguliai, Kleboniskis. bPetrasiunai.  
cTTHMs = total trihalomethanes: the sum of CHCl3 (chloroform), CHBr2Cl 
dibromochloromethane), and CHBrCl2 (bromodichloromethane).  
dSD = standard deviation.  
Table 1. Mean THM levels (μg/L) by sampling site and water supply zone 
3.2 Preterm birth risk factors 
The women recruited were predominantly Lithuanian in ethnic origin (97.4%) and did not 
smoke (93.1%) (Table 2). The mean age was 28.4 years, and the women tended to be highly 
educated (54.3% with a university degree). In general, mothers who were single, less 
educated, had previous preterm delivery, or reported a chronic stress delivered a higher 
proportion of preterm birth infants. We did not find a difference in preterm birth between 
water filter users and non-users.  
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Risk factors Characteristics All participants 
N( % ) 
Preterm birth 
N( % ) 
Maternal age 
 
< 20 years 
20–29 years 
 30 years 
95 (2.8) 
1961 (58.7) 
1285 (38.5) 
4 (2.1) 
107 (55.7) 
81 (42.2) 
Marital status* 
 
Married 
Not married 
2744 (82.1) 
597 (17.9) 
147 (76.6) 
45 (23.4) 
Maternal education* 
 
Primary school 
Secondary school 
University degree 
166 (5.0) 
1361 (40.7) 
1814 (54.3) 
16 (8.4) 
88 (45.8) 
88 (45.8) 
Maternal smoking 
 
Non-smoker 
Smoker 
3110 (93.1) 
231 (6.9) 
176 (91.7) 
16 (8.3) 
Paternal smoking 
 
Non-smoker 
Smoker 
1748 (52.9) 
1558 (47.1) 
88 (46.1) 
103 (53.9) 
Alcohol consumption 
 
No 
Yes 
3142 (94.0) 
199 (6.0) 
182 (94.8) 
10 (5.2) 
Blood pressure 
(mm/Hg) 
<140/80  
≥140 or ≥ 90  
2882 (86.3) 
459 (13.7) 
163 (84.9) 
29 (15.1) 
Ethnic group 
 
Lithuanian 
Other 
3254 (97.4) 
87 (2.6) 
191 (99.5) 
1 (0.5) 
Parity 
 
No child 
≥ 1 child 
1507 (45.1) 
1834 (54.9) 
85 (44.3) 
107 (55.7) 
Infant gender 
 
Male 
Female 
1714 (51.3) 
1627 (48.7) 
92 (47.9) 
100 (52.1) 
Current residence 
 
1–4 years 
5–9 years 
≥ 10 years 
1401 (41.9) 
841 (25.2) 
1099 (32.9) 
84 (43.7) 
46 (24.0) 
62 (32.3) 
Work exposure 
 
No 
Yes 
3048 (91.2) 
293 (8.8) 
177 (92.2) 
15 (7.8) 
Chronic disease 
 
No 
Yes 
2527 (75.6) 
814 (24.4) 
136 (70.8) 
56 (29.2) 
Previous preterm 
delivery* 
No 
Yes 
3279 (98.1) 
62 (1.9) 
180 (93.7) 
12 (6.3) 
Socio economic status 
 
Low income 
Medium income 
High income 
1010 (30.2) 
1824 (54.6) 
507 (15.2) 
68 (35.4) 
95 (49.5) 
29 (15.1) 
Body mass index  
(kg/m2) 
 
<25 Normal 
25–30 Overweight 
30 Obesity 
1974 (59.1) 
947 (28.3) 
420 (12.6) 
118 (61.5) 
49 (25.5) 
25 (13.0) 
Water filter 
 
Yes 
No 
1015 (30.4) 
2326 (69.6) 
64 (33.3) 
128 (66.7) 
Water supply area 
 
Petrasiunai 
Other 
1835 (54.9) 
1506 (45.1 
114 (59.3) 
78 (40.7) 
Birth year* 
 
2007 
2008 
2009 
681 (20.4) 
1711 (51.2) 
949 (28.4) 
48 (25.0) 
78 (40.6) 
66 (34.4) 
Maternal stress* No 
Yes 
2432 (72.8) 
909 (27.2) 
128 (66,7) 
64 (33.3) 
 
*p<0.05.  
Table 2. Distribution of Kaunas cohort study subjects for various characteristic 
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The analysis by TTHM internal dose tertiles showed, that most characteristics of the 
exposure groups were similar (Table 3). There were no differences in social and 
demographic characteristics, health behaviour, pregnancy history, and maternal diseases. 
However, paternal smoking and alcohol consumption differed between exposure groups. 
All subjects of high THM exposure group were served by Petrasiunai water treatment plant 
while 99.8% subjects of low exposure group were served by other water treatment plants. 
Among 3,341 singleton infant, 192 (5.7%) were classified as preterm birth. The proportion of 
premature birth cases tended to be higher among women of medium and high THM 
exposure to compare to low THM exposure.  
3.3 Association between THM internal dose and preterm birth risk 
Using total gestational and trimester-specific daily uptakes tertiles of TTHM and 
individual THMs continuous variables, we examined the association between internal 
dose and preterm birth risk (Table 4). In THMs analysis by tertile, preterm birth risk 
tended to increase by increasing internal dose, however, data for TTHM and chloroform 
were not consistent. TTHM and chloroform analysed as continuous variables (increase of 
0.1 μg/d) showed slightly elevated, but statistically non-significant increase in risk of 
preterm birth in all pregnancy trimesters. However, we found dose–response 
relationships for the first and second trimester’s bromodichloromethane and 
dibromochloromethane internal dose and risk for preterm birth. The adjusted odds ratio 
for third tertile vs. first tertile dibromochloromethane internal dose of first trimester was 
2.06, 95% CI 1.28–3.31; of second trimester the OR was 1.84, 95% CI 1.04–3.26; the OR per 
every 0.01 μg/d increase in dibromochloromethane internal dose was 1.28, 95% CI 1.04–
1.57 and 1.21, 95% CI 1.01–1.45,respectively, for first and second trimester. The trend was 
not statistically significant when dibromochloromethane exposure were examined. The 
analyses were adjusted for the variables that have had effect on preterm birth risk: family 
status, maternal education, smoking, alcohol consumption, stress, previous preterm 
delivery, and infant birth year. 
We used THM internal dose median level as a cut off (above median vs. below median) in a 
genetic polymorphism analyses. When GSTM1 genotype was considered, the association 
between exposure to THM and preterm birth differed by genotype: OR for preterm birth 
among women exposed to TTHM above median during the second trimester pregnancy was 
1.03 (95% CI 0.52–2.06) and 2.07 (95% CI 1.00–4.35) for the present and absent genotype, 
respectively. The findings were similar for chloroform and bromodichloromethane: in 
carriers of GSTM1-0 genotype exposure was associated with higher OR than in carriers of 
GSTM1-1 genotype for all three trimesters. However, these findings were not evident when 
the dibromochloromethane exposures were analyzed. The OR for preterm birth among 
women exposed to dibromochloromethane during the second trimester was 4.33 (95% CI 
1.69–11.10) and 1.69 (95% CI 0.0.78–3.64) for the present and absent genotypes, respectively. 
The findings suggest that carriers of the GSTT1–0 genotype and exposed to TTHM, 
chloroform and bromodichloromethane had an increased risk for preterm birth compared to 
carriers of the GSTT1–1 genotype: the ORs during the second trimester among woman 
GSTT1–1 genotype carriers were 1.03–1.17, while among  GSTT1–0 genotype carriers ORs 
were 2.46–3.08. Exposure to dibromochloromethane during the second trimester among 
carriers of the GSTT1–1 genotype was associated with an OR of 2.89, 95% CI 1.46–5.69, and 
among carriers of the GSTT1–0 genotype produced an OR of 1.42, 95% CI 0.43–4.64.  
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Risk factors Characteristics Low THM 
N (%) 
Medium THM 
N (%) 
High THM 
N (%) 
Maternal age 
 
< 20 years 
20–29 years 
 30 years 
19 (1.8) 
652 (60.1) 
414 (39.2) 
17 (1.5) 
688 (59.7) 
447 (38.8) 
23 (2.1) 
658 (59.6) 
423 (38.3) 
Marital status 
 
Married 
Not married 
876 (80.7) 
209 (19.3) 
958 (83.2) 
194 (16.8) 
910 (82.4) 
194 (17.6) 
Maternal education 
 
Primary school  
Secondary school 
University degree 
59 (5.4) 
454 (41.8) 
572 (52.7) 
50 (4.3) 
465 (40.4) 
637 (55.3) 
57 (5.2) 
442 (40.0) 
605 (54.8) 
Maternal smoking 
 
Non-smoker 
Smoker 
1003 (92.4) 
82 (7.6) 
1076 (93.4) 
76 (6.6) 
1031 (93.4) 
73 (6.6) 
Paternal smoking* 
 
Non-smoker 
Smoker 
574 (53.4) 
501 (46.6) 
629 (55.4) 
507 (44.6) 
545 (49.8) 
550 (50.2) 
Alcohol consumption* 
 
No  
Yes 
1000 (92.2) 
85 (7.8) 
1094 (95.0) 
58 (5.0) 
1048 (94.9) 
56 (5.1) 
Blood pressure 
(mm/Hg) 
<140/80  
≥140 or ≥ 90  
969 (89.3) 
116 (10.7) 
1020 (88.5) 
132 (11.5) 
977 (88.5) 
127 (11.5) 
Ethnic group 
 
Lithuanian 
Other 
1054 (97.1) 
31 (2.9) 
1117 (97.0) 
35 (3.0) 
1082 (98.1) 
21 (1.9) 
Parity  
 
No child 
≥ 1 child 
492 (45.3) 
593 (54.7) 
499 (43.3) 
653 (56.7) 
516 (46.7) 
588 (53.3) 
Infant gender  
 
Male 
Female 
559 (51.5) 
526 (48.5) 
611 (53.0) 
541 (47.0) 
544 (49.3) 
560 (50.7) 
Current residence 
 
1–4 years 
5–9 years 
≥ 10 years 
437 (40.3) 
257 (23.7) 
391 (36.0) 
492 (42.7) 
288 (25.0) 
372(32.3) 
472 (42.8) 
296 (26.8) 
336 (30.4) 
Work exposure 
 
No 
Yes 
996 (91.8) 
89 (8.2) 
1053 (91.4) 
99 (8.6) 
999 (90.5) 
105 (9.5) 
Chronic disease 
 
No 
Yes 
825 (76.0) 
260 (24.0) 
858 (74.5) 
294 (25.5) 
844 (76.4) 
260 (23.6) 
Previous preterm  
 
No  
Yes 
1069 (98.5) 
16 (1.5) 
1123 (97.5) 
29 (2.5) 
1087 (98.5) 
17 (1.5) 
Socio economic status 
 
Low income 
Medium income 
High income 
335 (30.9) 
582 (53.6) 
168 (15.5) 
337 (29.3) 
642 (55.7) 
173 (15.0) 
338 (30.6) 
600 (54.3) 
166 (15.0) 
Body mass index 
(kg/m2) 
 
<25 Normal 
25–30 Overweight 
30 Obesity 
618 (57.0) 
329 (30.3) 
138 (12.7) 
677 (58.8) 
334 (29.0) 
141 (12.2) 
679 (61.5) 
284 (25.7) 
141 (12.8) 
Water filter 
 
Yes 
No 
341 (31.4) 
744 (68.6) 
336 (29.2) 
816 (70.8) 
338 (30.6) 
766 (69.4) 
Water supply area* 
 
Petrasiunai 
Other 
2 (0.2) 
1084 (99.8) 
728 (63.3) 
422 (36.7) 
1105 (100.0) 
0 (0.0) 
Birth year* 
 
2007 
2008 
2009 
266 (24.5) 
524 (48.3) 
296 (27.3) 
91 (7.9) 
680 (59.1) 
379 (33.0) 
324 (29.3) 
507 (45.9) 
274 (24.8) 
Maternal stress 
 
No 
Yes 
794 (73.1) 
292 (26.9) 
848 (73.7) 
302 (26.3) 
790 (71.5) 
315 (28.5) 
Preterm birth 
 
No 
Yes 
1032 (95.0) 
54 (5.0) 
1079 (93.8) 
71 (6.2) 
1038 (93.9) 
67 (6.1) 
*p<0.05.  
Table 3. Distribution of Kaunas cohort study subjects for various characteristic by THM 
exposure 
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THM dose tertile 
limits (µg/d) 
Cases Controls Entire pregnancy  
OR (95% CI) 
I trimester 
OR (95% CI) 
II trimester  
OR (95% CI) 
III trimester 
 OR (95% CI) 
THM       
0.0025-0.0386 54 1032 1 1 1 1 
0.0386-0.3496 71 1079 1.35 (0.93-1.96) 1.51 (1.04-2.18) 1.34 (0.92-1.95) 1.47 (1.01-2.14) 
0.3496-2.4040 67 1038 1.24 (0.85-1.80) 1.09 (0.74-1.61) 1.18 (0.81-1.72) 1.10 (0.76-1.59) 
Continuous (0.1µg/d) 1.02 (0.98-1.07) 1.01 (0.97-1.06) 1.03 (0.98-1.07) 1.02 (0.98-1.07) 
Chloroform     
0.0013-0.0249 55 1035 1 1 1 1 
0.0249-0.2868 73 1072 1.38 (0.95-2.02) 1.65 (1.13-2.42) 1.38 (0.94-2.02) 1.67 (1.13-2.47) 
0.2868-2.1328 64 1042 1.14 (0.78-1.66) 1.15 (0.78-1.69) 1.16 (0.79-1.68) 1.20 (0.82-1.76) 
Continuous (0.1µg/d) 1.03 (0.97-1.08) 1.01 (0.96-1.07) 1.03 (0.98-1.08) 1.03 (0.98-1.08) 
BDCM       
0.0001-0.0124 62 1029 1 1 1 1 
0.0124-0.0501 61 1085 1.02 (0.70-1.49) 1.26 (0.87-1.83) 1.21 (0.83-1.76) 1.02 (0.70-1.50) 
0.0501-0.3359 69 1035 1.17 (0.82-1.68) 1.27 (0.88-1.85) 1.32 (0.91-1.90) 1.11 (0.78-1.60) 
Continuous (0.01µg/d) 1.02 (0.99-1.05) 1.02 (0.98-1.06) 1.02 (0.98-1.06) 1.02 (0.99-1.05) 
DBCM       
0.0000-0.0000 64 1051 1 1 1 1 
0.0000-0.0039 59 1065 1.40 (0.82-2.39) 1.51 (0.91-2.51) 1.79 (1.03-3.13) 0.83 (0.51-1.36) 
0.0039-0.0644 69 1033 1.67 (0.97-2.85) 2.06 (1.28-3.31) 1.84 (1.04-3.26) 1.11 (0.70-1.77) 
Continuous (0.01µg/d) 1.20 (0.99-1.46) 1.28 (1.04-1.57) 1.21 (1.01-1.45) 1.12 (0.94-1.32) 
Adjusted for: family status, smoking, education, alcohol consumption, stress, previous preterm birth, 
and infant bPirth year. 
Table 4. Preterm birth adjusted OR and 95% confidence intervals for entire pregnancy and 
trimester–specific internal THM dose  
THM exposure* GSTM1-1 
GS (95% PI) 
GSTM1-0 
GS (95% CI) 
GSTT1-1 
GS (95% CI) 
GSTT1-0 
GS (95% CI) 
TTHM 
Entire pregnancy 1.00 (0.50–1.99) 1.86 (0.89–3.88) 1.06 (0.61–1.83) 2.55 (0.82–7.97) 
First trimester 1.05 (0.53–2.10 ) 1.91 (0.91–4.01) 1.13 (0.65–1.96) 2.46 (0.79–7.67) 
Second trimester 1.03 (0.52–2.06) 2.07 (1.00–4.35) 1.17 ( 0.67–2.03) 2.46 (0.80–7.68) 
Third trimester 1.00 (0.50–2.00) 1.59 (0.77–3.28) 0.99 (0.87–1.72) 2.30 (0.76–6.99) 
Chloroform 
Entire pregnancy 1.00 (0.50–1.99) 1.83 (0.88–3.81) 1.05 (0.61–1.83) 2.46 (0.79–7.67) 
First trimester 1.04 (0.52–2.07) 1.86 (0.88–3.91) 1.11 (0.64–1.92) 2.46 (0.79–7.67) 
Second trimester 1.03 (0.52–2.06) 1.97 (0.94–4.15) 1.14 (0.65–1.97) 2.66 (0.85–8.29) 
Third trimester 1.00 (0.50–2.01) 1.69 (0.82–3.49) 1.03 (0.59–1.78) 2.49 (0.82–7.60) 
BDCM** 
Entire pregnancy 1.06 (0.53–2.13) 1.66 (0.80–3.45) 1.03 (0.59–1.79) 2.63 (0.85–8.09) 
First trimester 1.01 (0.51–2.01) 1.56 (0.76–3.22) 0.98 (0.56–1.69) 2.52 (0.83–7.65) 
Second trimester 1.11 (0.55–2.21) 1.66 (0.80–3.45) 1.03 (0.59–1.79) 3.08 (0.97–9.75) 
Third trimester 1.06 (0.53–2.13) 1.69 (0.81–3.51) 1.04 (0.60–1.80) 2.63 (0.85–8.09) 
DBCM** 
Entire pregnancy 2.02 (0.85–4.79) 1.61 (0.76–3.42) 1.76 (0.93–3.34) 1.37 (0.43–4.38) 
First trimester 7.35 (2.62–20.6) 2.81 (1.21–6.52) 4.29 (2.06–8.93) 2.47 (0.68–8.95) 
Second trimester 4.33 (1.69–11.1) 1.69 (0.78–3.64) 2.89 (1.46–5.69) 1.42 (0.43–4.64) 
Third trimester 2.51 (0.99–6.39) 1.34 (0.62–2.89) 1.88 (0.97–3.66) 0.96 (0.29–3.11) 
*Referent group bellow median. 
Adjusted for: family status, smoking, education, stress, previous preterm birth, and infant birth year. 
Table 5. Preterm birth adjusted OR and 95% confidence intervals for trimester–specific and 
entire pregnancy internal THM dose according to maternal polymorphisms in the GST gene 
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3.4 Distribution preterm birth risk factors by NO2 exposure levels 
Distribution of pregnancy outcomes and NO2 pollution levels are presented in Figure 1. 
The mean levels of NO2 to which the women were exposed outside their homes 
throughout their pregnancies ranged from 5.3 to 36.0 µg/m3. Table 6 shows the 
prevalence of distribution of Kaunas cohort study subjects for various characteristic by 
nitrogen dioxide exposure. There were no differences in social and demographic 
characteristics, health behaviour, pregnancy history, maternal diseases and health 
behaviour between the three NO2 exposure groups.  
 
Risk factors All participants 
N( % ) 
Low NO2 
N (%) 
Medium NO2 
N (%) 
High NO2 
N (%) 
Maternal age 
< 20 years 
20–29 years 
 30 years 
 
95 (2.8) 
1935 (58.8) 
1264 (38.4) 
 
34 (3.0) 
655 (58.3) 
434 (38.6) 
 
31 (2.9) 
663 (61.2) 
389 (35.9) 
 
28 (2.6) 
617 (56.8) 
441 (40.6) 
Marital status 
Married 
Not married 
 
2707 (82.2) 
585 (17.8) 
 
920 (81.9) 
203 (18.1) 
 
888 (82.0) 
195 (18.0) 
 
899 (82.8) 
187 (17.2) 
Maternal education 
Primary school  
Secondary school 
University degree 
 
162 (4.9) 
1340 (40.7) 
1790 (54.4) 
 
52 (4.6) 
483 (43.0) 
588 (52.4) 
 
55 (5.1) 
412 (38.0) 
616 (56.9) 
 
55 (5.1) 
445 (41.0) 
586 (54.0) 
Maternal smoking 
Non-smoker 
Smoker 
 
3066 (93.1) 
226 (6.9) 
 
1049 (93.4) 
74 (6.6) 
 
1009 (93.2) 
74 (6.8) 
 
1008 (92.8) 
78 (7.2) 
Paternal smoking 
Non-smoker 
Smoker 
 
1721 (52.8) 
1536 (47.2) 
 
589 (52.6) 
530 (47.4) 
 
593 (55.4) 
477 (44.6) 
  
539 (50.5) 
529 (49.5) 
Alcohol consumption 
No  
Yes 
 
3095 (94.0) 
197 (6.0) 
 
1054 (93.9) 
69 (6.1) 
 
1016 (93.8) 
67 (6.2) 
 
1025 (94.4) 
61 (5.6) 
Blood pressure 
<140/80 mm/Hg 
≥140 or ≥ 90 mm/Hg 
 
2841 (86.3) 
451 (13.7) 
 
989 (88.1) 
134 (11.9) 
 
 925 (85.4) 
158 (14.6) 
 
927 (85.4) 
159 (14.6) 
Ethnic group 
Lithuanian 
Other 
 
3205 (97.4) 
87 (2.6) 
 
1094 (97.4) 
29 (2.6) 
 
1054 (97.3) 
29 (2.7) 
 
1057 (97.3) 
29 (2.7) 
Parity  
No child 
≥ 1 child 
 
1487 (45.2) 
1805 (54.8) 
 
493 (43.9) 
630 (56.1) 
 
500 (46.2) 
583 (53.8) 
 
494 (45.5) 
592 (54.5) 
Infant gender * 
Male 
Female 
 
1690 (51.3) 
1602 (48.7) 
 
615 (54.8) 
508 (45.2) 
 
543 (50.1) 
540 (49.9) 
 
532 (49.0) 
554 (51.0) 
Current residence 
1–4 years 
5–9 years 
≥ 10 years 
 
1381 (42.0) 
831 (25.2) 
1080 (32.8) 
 
480 (42.7) 
266 (23.7) 
377 (33.6) 
 
468 (43.2) 
256 (23.6) 
359 (33.1) 
 
433 (39.9) 
309 (28.5) 
344 (31.7) 
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Work h/week during 1st trimester 
Nonemployed 
<10 h. 
10-20 h. 
20-40 h. 
> 40 h. 
 
 
537 (16.0) 
305 (9.3) 
138 (4.2) 
1785 (54.2) 
537 (16.3) 
 
 
172 (15.3) 
102 (9.1) 
45 (4.0) 
597 (53.2) 
207 (18.4) 
 
 
161 (14.9) 
104 (9.6) 
40 (3.7)  
612 (56.5) 
166 (15.3) 
 
 
194 (17.9) 
99 (9.1) 
53 (4.9) 
576 (53.0) 
164 (15.1) 
Chronicle disease 
No 
Yes 
 
2487 (75.5) 
805 (24.5) 
 
847 (75.4) 
276 (24.6) 
 
839 (77.5) 
244 (22.5) 
 
801 (73.8) 
285 (26.2) 
Previous preterm 
No  
Yes 
 
3231 (98.1) 
61 (1.9) 
 
1102 (98.1) 
21 (1.9) 
  
1061 (98.0) 
22 (2.0) 
 
1068 (98.3) 
18 (1.7) 
Socio economic status 
Low income 
Medium income 
High income 
 
994 (30.2) 
1799 (54.6) 
499 (15.2) 
 
344 (30.6) 
605 (53.9) 
174 (15.5) 
 
300 (27.7) 
623 (57.5) 
160 (14.8) 
 
350 (32.2) 
571 (52.6) 
165 (15.2) 
Body mass index 
<25 Normal 
25–30 Overweight 
30 Obesity 
 
1951 (59.3) 
926 (28.1) 
415 (12.6) 
 
663 (59.0) 
320 (28.5) 
140 (12.5) 
 
642 (59.3) 
309 (28.5) 
132 (12.2) 
 
646 (59.5) 
297 (27.3) 
143 (13.2) 
Birth year* 
2007 
2008 
2009 
 
671 (20.4) 
1688 (51.3) 
933 (28.3) 
 
205 (18.3) 
572 (50.9) 
346 (30.8) 
 
209 (19.3) 
551 (50.9) 
323 (29.8) 
 
257 (23.7) 
565 (52.0) 
264 (24.3) 
Maternal stress 
No 
Yes 
 
2397 (72.8) 
891 (27.2) 
 
830 (73.9) 
293 (26.1) 
 
782 (72.2) 
301 (27.8) 
 
785 (72.3) 
301 (27.7) 
Preterm birth 
No 
Yes 
 
3105 (94.3) 
187 (5.7) 
 
1061 (94.5) 
62 (5.5) 
 
1026 (94.7) 
57 (5.3) 
 
1018 (93.7) 
68 (6.3) 
*p<0.05  
Table 6. Distribution of Kaunas cohort study subjects for various characteristic by nitrogen 
dioxide exposure 
3.5 Association between NO2 exposure and preterm birth risk 
In crude analyses, we found consistently higher, statistically non-significant, ORs for 
preterm birth before 37 weeks associated with higher NO2 levels during the entire 
pregnancy and during the three trimesters of pregnancy (Table 7). Fully adjusted models by 
trimesters revealed exposure–response relationships for the entire pregnancy and trimester-
specific NO2 tertile and risk for preterm birth, however, none of these associations reached 
statistical significance. After adjustment for confounding variables, strongest relation 
between preterm birth and NO2 levels was in the first and in the second trimesters of 
pregnancy. The OR for preterm birth among women exposed to third tertile NO2 during the 
first trimester was 1.28 (95% CI 0.87–1.90) and 1.42 (95% CI 0.96–2.11) for the second 
trimester, respectively, to compare to the first NO2 exposure tertile. During the third 
pregnancy trimester third NO2 exposure tertile was associated with OR 1.12 (95% CI 0.76–
1.67), compared with the lowest NO2 exposure. Using a continuous measure, we found that 
the risk of preterm birth for entire pregnancy tended to increase by 22 % (adjusted OR = 
1.22, 95% CI 0.94–1.56) per every 10 μg/m3 increase in NO2 concentrations. There was no 
statistically significant association between preterm birth and NO2 exposure.  
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NO2 exposure tertiles 
Preterm birth 
(<37 weeks) 
Control 
 (>37 weeks) 
Crude  
odds ratio  
OR (95% CI) 
Adjusted* 
odds ratio  
OR (95% CI) N % N % 
Entire pregnancy       
1st tertile (6.4-18.7 µg/m3) 50 5.0 958 95.0 1 1 
2nd tertile (18.7-23.7 µg/m3) 50 4.9 966 95.1 0.99 (0.66-1.48) 0.99 (0.66-1.49) 
3rd tertile (23.7-44.3 µg/m3) 67 6.8 922 93.2 1.39 (0.96-2.03) 1.44 (0.98-2.11) 
Continuous variable (per 10 μg/m3 
increase in concentration) 
    1.19 (0.93-1.53) 1.22 (0.94-1.56) 
First trimester       
1st tertile (5.3-16.7 µg/m3) 55 5.2 994 94.8 1 1 
2nd tertile (16.7-24.0 µg/m3) 51 5.2 921 94.8 1.00 (0.68-1.48) 1.04 (0.70-1.55) 
3rd tertile (24.0-53.2 µg/m3) 61 6.1 931 93.9 1.18 (0.81-1.72) 1.28 (0.87-1.90) 
Continuous variable (per 10 μg/m3 
increase in concentration) 
    1.07 (0.88-1.28) 1.11 (0.91-1.35) 
Second trimester       
1st tertile (5.3-16.7 µg/m3) 47 4.8 936 95.2 1 1 
2nd tertile (16.7-24.5 µg/m3) 56 5.4 989 94.6 1.13 (0.76-1.68) 1.15 (0.77-1.73) 
3rd tertile (24.5-53.2 µg/m3) 64 6.5 921 93.5 1.38 (0.94-2.04) 1.42 (0.96-2.11) 
Continuous variable (per 10 μg/m3 
increase in concentration) 
    1.14 (0.95-1.37) 1.15 (0.96-1.39) 
Third trimester       
1st tertile (5.3-16.7 µg/m3) 53 5.1 977 94.2 1 1 
2nd tertile (16.7-24.2 µg/m3) 58 5.7 958 94.2 1.12 (0.76-1.64) 1.12 (0.76-1.66) 
3rd tertile (24.2-51.9 µg/m3) 56 5.8 911 94.6 1.13 (0.77-1.67) 1.12 (0.76-1.67) 
Continuous variable (per 10 μg/m3 
increase in concentration) 
    1.10 (0.92-1.32) 1.09 (0.90-1.31) 
Adjusted for: maternal smoking, education, family status, chronic diseases, previous 
preterm birth, stress, gender, and birth year. Parity below 4 children.  
Table 7. Crude and adjusted odds ratios (OR) and their 95% confidence intervals (CI) for 
preterm birth by trimester–specific and entire pregnancy NO2 exposure  
 
Genotype NO2 tertiles limits 
(µg/m3) 
Total 
N 
Preterm 
birth (%) 
Crude 
OR 95% CI 
Adjusted* 
OR 95% CI 
GSTT1-1 
 
I tertile (5.3-16.7) 171 16 (9.4) 1 1 
II tertile (16.7-24.5) 146 14 (9.6) 1.03 (0.48-2.18) 1.05 (0.47-2.36) 
III tertile (24.5-53,2) 187 25 (13.4) 1.50 (0.77-2.90) 1.64 (0.80-3.38) 
GSTT1-0 
 
I tertile (5.3-16.7) 46 6 (13.0) 1 1 
II tertile (16.7-24.5) 30 5 (16.7) 1.33 (0.37-4.83) 1.21 (0.27-5.44) 
III tertile (24.5-53,2) 26 9 (34.6) 3.53 (1.09-11.5) 5.44 (1.29-22.9) 
GSTM1-1 
     
I tertile (5.3-16.7) 107 12 (11.2) 1 1 
II tertile (16.7-24.5) 96 6 (6.3) 0.53 (0.19-1.47) 0.50 (0.17-1.44) 
III tertile (24.5-53,2) 111 17 (15.3) 1.43 (0.65-3.16) 1.42 (0.62-3.26) 
GSTM1-0 
 
I tertile (5.3-16.7) 110 10 (9.1) 1 1 
II tertile (16.7-24.5) 80 13 (16.3) 1.94 (0.80-4.68) 1.90 (0.68-5.25) 
III tertile (24.5-53,2) 102 17 (16.7) 2.00 (0.87-4.60) 2.65 (1.03-6.83) 
* Adjusted for: maternal smoking, education, family status, chronic diseases, previous 
preterm birth, stress, and birth year.  
Table 8. Crude and adjusted associations as odds ratios (OR) of NO2 exposure during entire 
pregnancy with preterm birth by maternal genotypes 
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Fig. 1. Modelled NO2 concentration and geocoded study subjects addresses 
4. Discussion 
4.1 Trihalomethanes effects 
We conducted a prospective cohort study to examine the effects of internal dose of THM 
during the entire pregnancy and during three trimesters on preterm births before 37 weeks. 
TTHM and chloroform analysed as continuous variables (increase of 0.1 μg/d) showed 
slightly elevated, but statistically non-significant increase in risk of preterm birth in all 
pregnancy trimesters. However, we found dose–response relationships for the first and 
second trimester’s bromodichloromethane and dibromochloromethane internal dose and 
risk for preterm birth. The adjusted ORs for third tertile vs. first tertile 
dibromochloromethane internal dose of first trimester was 2.06, 95% CI 1.28–3.31; of second 
trimester the OR was 1.84, 95% CI 1.04–3.26. The probability of delivering a preterm birth 
infant was elevated by 28% per every 0.01 μg/d increase in dibromochloromethane internal 
dose (OR 1.28, 95% CI 1.04–1.57) and by 21% (OR 1.21, 95% CI 1.01–1.45), respectively, for 
first and second trimester. The lack of statistically significant effects for other TTHM 
constituents may be due to low exposure because of low levels, and lack of power in our 
study sample. 
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Consistent with other recent studies (Källén & Robert; 2000; Lewis et al., 2007; 
Nieuwenhuijsen et al., 2009) our findings suggest that THM exposures might increase the 
risk of preterm birth. The epidemiological evidence for an association between exposure to 
THM and preterm birth is relatively inconsistent. A number of prior investigations have 
evaluated crude exposure during the pregnancy. An epidemiological study reported a 
statistically significant increased risk of delivering a preterm birth infant among women 
users of chlorinated with sodium hypochlorite water vs. no chlorinated water, with OR of 
1.09 (CI 1.01–1.17) (Källén and Robert; 2000). Some authors found no association between 
preterm birth and THM (Aggazzotti et al., 2004; Hinckley et al., 2005). Some authors find 
small increases in gestation age with increased TTHM exposure and with both chloroform 
and BDCM (Wright et al., 2003; 2004). A negative association during the second trimester 
were reported, however, women who depended on a governmental source of payment for 
prenatal care were at increased risk when exposed at high levels TTHM late in gestation (OR 
1.39; 95% CI, 1.06–1.81) (Lewis et al., 2007).  
Lack of a consistent effect of the epidemiologic studies may be result of a study design, be a 
result of exposure misclassification or inadequate control for confounding variables, or a 
lack of power in studies sample, or actual lack of an effect of DBP on reproductive effects. 
This study offered advancement in individual internal dose assessment based on residential 
THM levels, detailed water use behaviours and exposure during pregnancy. Every subject’s 
exposure indices were estimated as daily internal dose of the THM constituents (mg/d) and 
birth outcome effects were assessed by using indices categorical variable and also as a 
continuous variable. An additional strength of our study is that pregnant women were 
prospectively followed, and did not move during pregnancy. This allowed collection of self 
reported data on potential confounding covariates and decreased of exposure 
misclassification errors. However, there is a possibility of confounding in our study, because 
of lack information on maternal nutrition, infection diseases, and occupational physical 
exposures (Magann et al., 2005). Furthermore, lack of information regarding the validity of 
the internal dose assessment models that we used is one of the limitations of this study, but 
again validity studies are difficult to conduct and are expensive.  
4.2 Maternal GSTT and GSTM genotypes effects 
Our study adds to the findings of researchers who studied genetic polymorphism along 
with to environmental toxicants (Nukui et al., 2004; Suh et al., 2008) in showing effect 
modification between mothers with and without GSTT1- and GSTM1- genotype variant and 
response to the environmental hazards. Adjusted ORs for preterm birth among women 
exposed to TTHM above median internal dose during the second trimester pregnancy was 
1.03 (95% CI 0.52–2.06) and 2.07 (95% CI 1.00–4.35) for the present and absent GSTM1 
genotype, respectively.  The findings suggest that carriers of the GSTT1–0 genotype and 
exposed to TTHM, chloroform and bromodichloromethane had an increased risk for 
preterm birth compared to carriers of the GSTT1–1 genotype: the ORs during the second 
trimester among woman GSTT1–1 genotype carriers were 1.03–1.17, while among GSTT1–0 
genotype carriers ORs were 2.46–3.08. Our data indicated that individuals with GSTT1 and 
GSTM1 null genotypes tended to be more susceptible to THM exposure.  
Our findings raises the possibility that the effect of TTHM exposure on preterm birth may be 
associated with one or two variant alleles for the GSTT and GSTM genes involved in the 
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metabolism of low doses of THMs. Further tests with larger sample sizes are needed to 
verify these observations. 
Although the effects of unmeasured risk factors could not be excluded with certainty, our 
findings suggest that genetically determined differences in maternal detoxification may 
contribute to the risk of preterm birth. In particular, women carriers of GSTT1 or GSTM1 
null genotypes and exposed to high levels of NO2 during the pregnancy were at a higher 
risk for preterm birth to compare to the GSTT1-1 and GSTM1-1 genotypes carriers. We 
observed a statistically significant association between maternal GSTT1 null genotype (OR 
5.44, 95% CI 1.29–22.9) and GSTM1 null genotype (OR 2.65, 95% CI 1.03–6.83) and the risk 
for preterm birth infants in the presence of maternal NO2 exposure of third tertile during 
pregnancy. This result provided evidence for a gene–environment interaction regarding a 
risk for preterm birth. 
To the best of our knowledge, this is the first study to explore the synergistic effect of the 
GSTT1 and GSTM1 polymorphism and exposure to NO2 on preterm birth. Limitations in 
interpreting these results include: there are other external exposures which we did not 
measure; the presence of internal uncontrolled exposures; GSTT1 and GSTM1 genes are 
linked to other genes responsible for preterm birth.  
4.3 NO2 exposure effects  
Our findings provide little support to the hypothesis of an adverse effect of maternal 
exposure to NO2 during pregnancy on preterm birth. NO2 exposure during entire 
pregnancy and during the three trimesters of pregnancy tended to be associated with 
increase in risk of preterm birth after adjustment for the main possible confounders: 
maternal smoking, education, family status, chronic diseases, previous preterm birth, stress, 
infant gender, and birth year. In this study we also were able to estimate residential NO2 
exposure to every cohort study subject during pregnancy trimesters and to control for effect 
of change residence during pregnancy. Adjusted odds ratios for preterm birth for entire 
pregnancy exposed to third tertile NO2 was found to be 1.44, 95% CI 0.98–2.11. The risk of 
preterm birth tended to increase by 22% (adjusted OR = 1.22, 95% CI 0.94–1.56) per 10 
μg/m3 increase in NO2 concentrations. A limited statistical power of the study may be 
associated with a low prevalence of preterm birth in our cohort (5.7 %) and also be a 
consequence of low NO2 exposure level, since only a low percentage of pregnant women 
were exposed to the levels exceeding established limit value of the annual mean NO2 
concentration (40 μg/m3).  
The results of the study confirm to a data of epidemiological studies performed in other 
countries. The reported NO2 effect on preterm birth was small with odds ratios in the range 
1.1–1.2 per 10 µg/m3 increase in NO2 levels or effect was not found (Gehring et al. 2011; Liu 
et al. 2003; Hansen et al. 2006; Ritz et al. 2007). Association of NO2 exposure and increased 
risk of preterm birth was reported during different trimesters (Bobak 2000; Lee et al. 2003). 
A study in Valencia, Spain, find that highest association  between NO2 levels during 
pregnancy and preterm birth was found in second trimester (1.11, 95 % CI 1.03- 1.21) (Llop 
et al. 2010). Consistent with the findings of a cohort study in Vancouver, Canada where 
association between preterm birth and NO2 concentrations was found during different 
periods of pregnancy (Liu et al. 2003), our findings suggest that NO2 exposure might 
increase the risk of preterm birth.  
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In our previous study we found a moderately increased preterm birth risk for NO2 
exposures estimated at the entire residential district level (Maroziene and Grazuleviciene 
2002). Adjusted ORs of preterm birth for the medium and high NO2 tertile exposures were 
OR = 1.14 (95% CI 0.77–1.68) and OR = 1.68 (95% CI 1.15–2.46), respectively. Using a 
continuous measure, the risk of preterm birth increased by 25% (adjusted OR = 1.25, 95% CI 
1.07–1.46) per 10 μg/m3 increase in NO2 concentrations.  
Potential mechanisms by which air pollution might increase preterm birth include 
inflammation, endotelian dysfunction, endocrine disruption and genetic polymorphisms 
(Slama et al., 2010; Suh et al., 2008; Yorifuji et al., 2011). 
Consistent with our finding, some previous studies found that exposure to maternal 
smoking or high levels of particulate matter in the presence of the GSTM1 null genotype is 
associated with the adverse birth outcomes (Sram et al., 2006; Suh et al., 2008; 
Grazuleviciene et al., 2009).  
To make progress, this research field needs input from molecular epidemiology, toxicology, 
exposure assessment, and epidemiology, especially to aid in the identification and exposure 
assessment of reproductive-toxic agents in water and ambient air, and in the development 
of early markers of adverse reproductive outcomes. Additional research that clearly defines 
the mechanisms by which risk factors are related to preterm birth is crucial. Improved 
understanding of these mechanisms should allow clinicians to design appropriate 
interventions so that the incidence of preterm birth and related fetal and neonatal morbidity 
and mortality will be reduced. Improved methods of characterizing patients based on  
etiology that allow for the evaluation of multiple candidate genes simultaneously are most 
likely to be successful in identifying genetic susceptibility that increase the risk for preterm 
birth. Futher research should focus on the use of individual environmental exposures and 
genetic susceptibility in the studies of environmental toxicants effects on birth outcomes. 
5. Conclusion  
This study presented epidemiological evidence for a dose-response relationship between 
dibromochloromethane internal dose and the risk for preterm birth. The analyses were 
adjusted for the confounding variables that have had effect on preterm birth risk: single 
women, low maternal education, smoking, alcohol consumption, stress, previous preterm 
delivery, and infant birth year. In addition, increased THM internal dose tended to increase 
preterm birth risk and maternal GSTM1 and GSTT1 genotypes modified the THM exposure 
effects on preterm birth. Furthermore, we found an association between exposure to high 
levels of NO2 during pregnancy and the presence of the GSTM1 null and GSTT1 null 
genotypes for the risk of preterm birth, providing evidence that both genetic and 
environmental factors determine complex traits such as preterm delivery. Genes involved in 
metabolic detoxification processes such as GSTM1 and GSTT1 may be treated as candidate 
risk factors for preterm birth. 
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